Skip to main content
. 2017 Sep 12;7:11306. doi: 10.1038/s41598-017-11751-7

Figure 3.

Figure 3

AZD4547 induces histoarchitectural and proliferative downregulation in premalignant mammary glands from MMTV-ErbB2 mice. 8-week-old MMTV-ErbB2 mice were administered AZD4547 (0, 2, or 6 mg/kg/day) for 10 weeks. Then mammary glands were excised for whole mount and histological analyses. Representative images of mammary gland whole mounts are shown in (a). Ductal branching complexity (the number of side branches in a 10 mm2 field, (b) was analyzed from the whole mounts. Four 10 mm2 fields were analyzed per sample to determine the branching densities. Mammary glands were also collected after AZD4547 treatments and processed for FFPE. The FFPE tissues were H&E stained (c) or processed for IHC staining of Ki67 (d). The percentages of Ki67+ cells are graphed below the panels of representative Ki67-stained tissues. All values are presented as the mean ± S.E. (** P ≤ 0.01).